Drinking water treatment by ferrate(VI) and toxicity assessment of the treated water by Jiang, Jia-Qian et al.
Drinking water treatment by ferrate(VI) and toxicity assessment of the treated water
Jiang, Jia-Qian; Prithiviraj Durai, Hari Babu; Petri, Michael ; Grummt, Tamara ;
Winzenbacher, Rudi
Published in:







Link to publication in ResearchOnline
Citation for published version (Harvard):
Jiang, J-Q, Prithiviraj Durai, HB, Petri, M, Grummt, T & Winzenbacher, R 2016, 'Drinking water treatment by
ferrate(VI) and toxicity assessment of the treated water', Desalination and Water Treatment, vol. 57, no. 54, pp.
26369-26375. https://doi.org/10.1080/19443994.2016.1203825
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please view our takedown policy at https://edshare.gcu.ac.uk/id/eprint/5179 for details
of how to contact us.





Drinking water treatment by ferrate(VI) and toxicity assessment of the treated 
water 
 
Jia-Qian Jiang,a,† Hari B P Durai,a Michael Petrib, Tamara Grummt,c Rudi Winzenbacherd 
aSchool of Engineering and Built Environment, Glasgow Caledonian University,  
Glasgow G4 0BA, Scotland, United Kingdom 
bZweckverband Bodensee-Wasserversorgung, Süßenmühle 1, 78354 Sipplingen, Germany 
cUmweltbundesamt,  Heinrich-Heine-Straße 12, D-08645 Bad Elster, Germany 
dZweckverband Landeswasserversorgung, Am Spitzigen Berg 1, 89129 Langenau, Germany 
†Corresponding author’s Email: jiaqian.jiang@gcu.ac.uk 
 
ABSTRACT 
The work presented in this paper was to identify whether ferrate(VI) can be used as an 
alternative to the existing FeCl3 in drinking water treatment plant at Lake Constance Water 
Supply of Germany. The performance of ferrate(VI) was tested in a pilot plant, which 
includes micro-screening, pre-ozonation, coagulation and rapid filtration processes. With a 
ferrate(VI) dose of 0.1 mg/L and without pH neutralization required, the average particle 
removal percentage (in terms of particle counting) after filtration was 93% for the raw water 
and 97% for the ozonized water, which is satisfied to the treated water quality demand for 
the particle removal. In comparison with using ozonation and FeCl3 coagulation, ferrate(VI) 
can remove 10% metformin, benzotiozole and acesulfam from raw water but FeCl3 with 





water did (~ 11 µg/L). Finally, ferrate(VI) can effectively replace both ferric chloride and 
hydrogen peroxide in terms of achieving the required treatment performance and minimizing 
residual ozone, and no interaction between genotoxic effects and ferrate(VI) treatment were 
observed. This adds promising benefit of using ferrate(VI) for the given water quality and 
operating conditions in drinking water treatment.  
Keywords: Coagulation; drinking water treatment; ferrate(VI); Genotoxicity test; micro 
pollutant reduction; ozonation;  particle removal  
1. Introduction 
Ferrate(VI) ion has the formula FeO42-, and is a very strong oxidant. Under acidic 
conditions, the redox potential of ferrate(VI) ions (2.2 V) is greater than that of ozone (2.0 
V) and is the strongest of all the oxidants/disinfectants practically used for water and 
wastewater treatment [1]. The exploration of the use of ferrate(VI) for water and wastewater 
treatment has been addressed [1-5]. The studies revealed that ferrate(VI) can disinfect 
microorganisms, partially degrade and/or oxidise organic and inorganic impurities, and 
remove suspended/colloidal particulate materials in a single dosing and mixing unit process. 
Most recently, researches have been reported using ferrate(VI) to treat emerging micro 
pollutants in water purification processes [6,7]. However, challenges have existed for the 
implementation of ferrate(VI) technology in practice due to the instability of a ferrate(VI) 
solution or high production cost of solid ferrate(VI) products. Research has been directed at 
the generation and application of ferrate(VI) in situ [8, 9]. Practical advantages of ferrate(VI) 





industry could implement the technology into full scale application. In doing so, a series of 
pilot scale trials using ferrate(VI) for water and waste water treatment are needed to establish 
the database of the comparative treatment performance and to assess the operating cost 
against the existing technologies.  
On the other hand, N-Nitroso-dimethyl-amine (NDMA) is highly toxic and NDMA's 
contamination of drinking water is of particular concern due to the minute concentrations at 
which it is harmful. The US Environmental Protection Agency (USEPA) has determined that 
the maximum admissible concentration of NDMA in drinking water is 7 ng L−1 [10]. 
Moreover, ozonation has been widely used for the pre-oxidation and disinfection in drinking 
water treatment and NDMA is to be formed in ozonation if a given precursor is presenting in 
raw water [11]. NDMA does not readily biodegrade, adsorb, or volatilize and thus is difficult 
to be removed from drinking water. Suggested technologies could be used to treat NDMA 
containing water [12] include high levels of UV irradiation in a wavelength of the 200 to 260 
nm range which breaks the N-N bond and reverse osmosis which is able to remove 
approximately 50% of NDMA. However, it is worth testing alternative technologies for  the 
removal of NDMA from drinking water.   
The work presented in this paper was a study following-up the previous work [13] on 
the use of in-situ generated ferrate(VI) for both drinking water and waste water treatment at 
pilot- and full-scale. The specific objectives of this research were to identify the optimal 
operating conditions of using ferrate(VI) to replace the existing chemicals in drinking water 





been detected the presence of both metformin and N,N-dimethyl-sulfamide (DMS), which 
have potential to produce NDMA when the lake water was chlorinated and/or ozonated [14-
15], and then,  experiments were carried out to examine the effect of using ferrate(VI) on the 
formation of NDMA in drinking water treatment. Finally, Genotoxicity tests were carried out 
to examine whether a ferrate (VI) treatment would result in any potential toxicity in the 
treated water. 
 
2. MATERIALS AND METHODS 
2.1. Materials  
Ferric chloride was obtained from the large scale plant in Lake Constance water 
Supply. Commercially available Metformin (1, 1-Dimethylbiguanide hydrochloride) (Sigma 
Aldrich) and N,N-dimethyl-sulfamide (DMS, Chemos Gmbh) was used to spike them into 
raw water for the test of the formation of NDMA after ferrate(VI) treatment. For the micro 
pollutants analysis, analytical standards were purchased from Dr. Ehrenstorfer (Augsburg, 
Germany) or Sigma-Aldrich (Steinheim, Germany). Ultra-pure water, methanol and 
acetonitrile with LC-MS grade were purchased from Carl Roth (Karlsruhe, Germany). 
Ammonium acetate, ammonium carbonate and acetic acid were analytical grade and 
obtained from Signal-Adrich (Steinheim, Germany). Ferrate production procedures have 
been described elsewhere [8]. Ferrate(VI) is unstable under neutral and acidic pHs. However, 
in this study, it was generated at high alkali conditions and used immediately after generation 






2.2. Pilot scale filtration trials after ferrate(VI) coagulation 
Pilot plant was designed and set up by Lake Constance Water Supply with designed 
parameters shown in Table 1 and photo 1. Water flows through a micro sieve filter (15µm), 
which filters all kinds of  large particles (including algae), and  then flows in to the 
customized ozone mixer followed by seven contact tanks. And then, ferrate and FeCl3 were 
pumped into two flowing water separately by peristaltic pumps with the required volume 
dosage. Water/coagulant mixtures were directed into two separated chambers where suitable 
flocculation occurred before the flow entered two parallel filter columns with similar flow 
conditions. Filter columns are made of steel tube running vertical with design parameters 
mentioned in Table 1. The operating conditions of filters can be seen in Table 2. 
 
Table 1.  
Design parameters of pilot plant filters  
 
Filter parameter Unit Details 
Total height m 3.6 
Filter area m2 0.283 
Average flow rate hr-1 ~1700 
Average flow velocity mh-1 ~6 
Running time hr 40-100 
Filter media  40 cm EVERZIT N (0.8-1.6mm); 60 cm Sand 

























Table 2.  
Pilot plant operating conditions (Fe dose = 0.1 mgL-1) 
Parameters Details 
Initial/final flow rate (L/h) 1500/1000 
Running time (h) 5-7 
Online measurement instrument  Particle counter; flow rate, pH and conductivity 
 
Final water sampling time  After 4 hrs of dosing coagulant 
Ozone dosing (mg/L) ~ 1.2 (dose); ~ 0.7 (at ozone mixer outlet) 
Residual ozone concentration 








2.3. Water quality analysis 
Analysis of various water quality parameters and residual ozone concentration 
followed the standard methods [16]. The formation of NDMA was measured by the gas 
chromatograph (GC) - mass spectrometer (MS) method with a solid phase extraction (SPE) 
before the measurement. Clarus 500 GC (Perkin-Elmer, Germany) coupled to a Perkin-
Elmer Clarus MS single quadrupole mass spectrometer (MS) was used. Coconut charcoal 
SPE cartridges (Resprep EPA-Method 521, Restek, Germany) were conditioned by rinsing 
with 3 x 3mL dichloromethane, 3 x 3 mL methanol and 3 x 3 mL ultrapure water. The 
sample volume was drawn under vacuum through the SPE-cartridges (flow rate 5-10 
ml/min). After loading, the cartridges were dried under gentle stream of air. The analytes 
were eluted with 4 x 2 mL dichloromethane into a 10 mL glass tube. Small amounts of water 
present were removed with 2 g sodium sulfate. The dried extracts were concentrated under a 
stream of nitrogen at 30°C to 1 mL and then transferred to 2 mL GC vials. The extracts were 
stored at -18°C until instrumental analysis.  
Analysis of micro pollutants, Metformin benzotiozole and acesulfam, was carried out 
using an Agilent 1100 LC system (Agilent, Waldbronn, Germany) equipped with a API 4000 
triple quadrupole mass spectrometer with electrospray ionization (Applied Biosystems, 
Darmstadt, Germany). The column was an Ultra Aqueous C18 (250 mm x 4.6 mm) from 
Restek (Bad Homburg, Germany). Water (eluent A) and acetonitrile/water (95/5 Vol%/Vol%, 
eluent B) with 0.1 Vol% formic acid were used as mobile phase with a flow rate of 0.75 





were injected directly without any further sample pre-treatment. The eluent program started 
with 5% eluent B, increased linearly within 6 min to 80% eluent B and increased linearly 
from 6 to 12 min to 95% eluent B. After the analytic run the eluent was set back to 5% eluent 
B from 12 to 18 min. The LC-column was coupled to the mass spectrometer directly into the 
ion source which was heated to 650°C inside the ionization section with nitrogen gas flows 
of 40 psi for curtain gas and 60 psi for the ion source gases 1 and 2, respectively. The ion 
spray voltage was set to 5.5 kV. The mass spectrometer was operated in the positive mode. 
The detection of metformin was performed with three multiple reaction monitoring 
transitions: from m/z 130 to m/z 71 at a collision energy of 19 V, was from m/z 130 to m/z 
60 at a collision energy of 29 V and was from m/z 130 to m/z 85 at a collision energy of 25 
V. 
2.4. Genotoxicity assessment 
In the present study two genotoxicity tests were combined, namely the Salmonella 
typhimurium reverse mutation assay (Ames test) and the Micronucleus test (MN). The two 
test systems belong to the basic set of tools for genotoxicity testing and they are sufficient 
for achieving a satisfactory result for possible genotoxic effects. 
The Ames test was carried out as a plate incorporation assay following the DIN 38415-
4 [17]. To measure the micronuclei the in vitro MicroFlow® (Litron Laboratories, Rochester 
USA) was used. Based on the knowledge that most of the human genotoxic carcinogens 





HepaRGTM cells. The samples were tested direct and after concentration (1:1000) by using 
C18 Polar Plus® column and Oasis HLB. 
 
3. RESULTS AND DISCUSSION 
3.1. Removal of small particle (<2 µm)  
Lake Constance water has better quality and then the required coagulant dose was low 
(0.1 mg/L as Fe). For the given operating conditions (Table 2), particle removal percentage 
after filtration was  93% for raw water and 97% for the ozonized water (Figure 1). As can be 
seen in Fig. 1, there were larger numbers of 1 µm particles than that of 2 µm. For both raw 
water and ozonated water, two filters had different performance; Filter 1 achieved slightly 
better performance than Filter2. However, after dosing coagulants, such differences were 
extinct. 
3.2. NDMA formation after ferrate(VI) treatment  
When metformin was used as precursor no more than 2 ng/L of NDMA formation was 
observed after dosing 0.1 mg/L ferrate(VI) in the water treatment (Figure 2, Left). Initial 
metformin concentration did not result in great difference in the formation of NDMA. The 
reason for this is due to less reactivity between ferrate(VI) and metformin. 
When DMS was used as precursor, NDMA formation was affected by the concentration 
of spiked DMS and ferrate(VI) dose; high concentrated DMS (100 µg/L) resulted in high 
NDMA formation at high doses of ferrate(VI) (4-5 mg/L). On the other hand, relatively low 





ferrate(VI) dose was <5 mg/L (Figure 2, Right). 
Surveys of NDMA formation have been conducted and the work was reviewed [18]. In 
USA and Japan, the raw waters were found to contain NDMA in concentrations of 0–53 
ng/L. Chemical disinfection by chlorination, chloramination, chlorine dioxide and ozone 
caused an increase in NDMA concentrations. In Japan, ozonation was shown to increase 
substantially the NDMA concentrations in two waters. Significantly, more NDMA was found 
after advanced oxidation processes (AOP) (H2O2/UV) in some waters. Obviously, all 
oxidation processes will generate NDMA in water treatment; the real production and 
resulting NDMA concentration mainly depend on the raw water quality characteristics, the 
type and concentration of disinfectants and other operating conditions used.  
Fig. 1. Particle removal by coagulation at 0.1 mg/L as Fe and pilot plant filtration from raw 







Fig. 2. NDMA formation in Lake Constance water spiked with metformin (Left) and DMS 
(Right) (10 and 100 µg/L, respectively) and treated with ferrate(VI) (0.1 mg/L dose) 
 
3.3. Comparative performance of FeCl3 and ferrate(VI) 
Table 3 shows the comparative performance of ferrate(VI) and FeCl3 at 0.1 mg/L 
dosage in pilot scale experiments. Both performed similar in the removal of particles, UV-
abs and dissolved organic carbon (DOC) for the given conditions in the pilot plant. However, 
ferrate(VI) can achieve 10% reduction of metformin, benzotiozole and acesulfam but FeCl3 
with ozonation can’t. Moreover, ferrate(VI) treated water did not generate bromate but 
ozonated water did although the resulting bromate concentration was 11 µg/L.  
In Lake Constance Water Supply, hydrogen peroxide is used to remove residual ozone 
in the purified water before supplying to their customer, In this study, ferrate(VI) was dosed 
to ozonated water to examine if ferrate(VI) can be used to replace H2O2 and achieve the 








































from 0.7 mg/L (ozone dose at Lake Constance) to less than 0.1 mg/L within 15 minutes, 
which is satisfied by the company’s requirement.   
This work was carried out at the pilot plant where the operating conditions followed 
the main plants. And therefore, the ferrate(VI) dose used was very low, 0.1 mg Fe/L, in order 
to equality compare with the performance of ferric chloride and ozonation. Due to this, the 
relevant volume dose of ferrate(VI) was very low which did not affect the treated water pH.  
 
 










Table 3.  
Comparative performance of ferrate(VI)  and FeCl3 
 
3.4. Genotoxicity of the ferrate(VI) treated water 
The occurrence of genotoxicity in aquatic systems is a serious problem because of the 
risk to both human and ecosystem health. The systematic use of the basic test strategy can be 
a useful early warning system in the identification of toxicological hazards due to the 
implementation of any new treatment techniques, such as ferrate(VI) in this study. Table 4 
summarizes the toxicity assessment results. All ferrate(VI) treated water samples gave 
negative results in general. The water treatment scheme had no influence of the genotoxic 
activity. The addition of the metabolic system (Ames, S9-Mix) and the use of metabolic 
competent cells led to similar negative results, suggesting that ferrate(VI) treatment did not 
generate toxicity for the study conditions. 
   Unit 
Raw water Ozone water
Ferrate(VI) FeCl3 Ferrate(VI) FeCl3 
Fe dosage mg/L 0.1 
Turbidity % ~80 ~80 ~90 ~90 
UV-254 No change 
DOC No change 
Residual Fe µg/L ~16 ~9 ~15 ~12 
Particle removal % ~93 ~94 ~98 ~98 
Bromate formation µg/L 0 0 ~11 ~11 
Benzotiozole removal % 10 0 10 0 
Acesulfam removal % 10 0 10 0 
Metformin removal % 10 0 10 0 






Table 4.  
Summarized results of the genotoxicity testing 
Sample Genotoxicity 
  Ames test Micronucleus test/cell line 
  Direct SPE-
concentrated 
Hep G2 HepaRGTM 
Ferrate(VI) (0.1 mg/L) 
treated raw water 
T/420-2 - - - - 
Ferrate(VI) (0.1 mg/L) 
treated raw water  
T/420-3 - - - - 
Ferrate(VI) (0.5 mg/L) 
treated raw water 
T/420-4 - - - - 
Ferrate(VI) (0.1 mg/L) 
treated ozone water  
T/420-5 - - - - 
Ferrate(VI) (0.1 mg/L) 
treated ozone water  
T/420-6 - - - - 
Ferrate(VI) (0.5 mg/L)  
treated ozone water 
T/420-7 - - - - 
Raw water T/420-R - - - - 
 
4. Conclusions 
Pilot scale filtration experiments with dosing 0.1 mg/L of ferrate(VI) achieved the 





water in terms of particle counting data. No pH neutralization was required after dosing 
ferrate(VI). In comparison with using ozonation and FeCl3 coagulation, ferrate(VI) has the 
additional benefits; it did not significantly result in the formation of N-Nitroso-dimethyl-
amine (NDMA) after the treatment and can remove 10% metformin, benzotiozole and 
acesulfam but FeCl3 with ozonation can’t. Additionally, ferrate(VI) treated water did not 
generate bromate while ozonated water did.  Moreover, ferrate(VI) can effectively replace 
both ferric chloride and hydrogen peroxide in terms of achieving the required treatment 
performance and minimizing residual ozone. Finally, no interaction between genotoxic 
effects and ferrate(VI) treatment were observed. 
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